Error in template * unknown parameter name (Template:Infobox_drug): 'InChI; InChIKey; imagename' （参见参数表表。）
此错误不会显示于内文之中，仅会在预览时显示。
英语百科
Empagliflozin 恩格列净
Empagliflozin (trade name Jardiance) is a drug of the gliflozin class, approved for the treatment of type 2 diabetes in adults in 2014. It was developed by Boehringer Ingelheim and Eli Lilly and Company.
Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and causes sugar in the blood to be excreted by the kidneys and eliminated in urine.